CERo Therapeutics Holdings, Inc. - Common Stock (NQ:CERO)
Press Releases about CERo Therapeutics Holdings, Inc. - Common Stock
CERo Therapeutics Doses 7th Patient in Phase 1 CER-1236 Trial
November 03, 2026
Via GlobeNewswire
CERo Therapeutics Provides Shareholder Update
March 11, 2026
Via GlobeNewswire
CERo Therapeutics Announces Trading on OTCQB Market
December 02, 2025
Via GlobeNewswire
CERo Therapeutics Announces Listing on OTC Markets
November 03, 2025
Via GlobeNewswire
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
October 29, 2025
Via GlobeNewswire